NovaSignal is a medical technology company specializing in assessing cerebral blood flow. Utilizing their Lucid Robotic System, they use cloud computing and data analytics to support physicians in their clinical decision making of diseases identified through cerebral blood flow, including strokes, intr-cardiac shunts, and intra-pulmonary shunts (as recently demonstrated with COVID-19-positive patients).